Hybrid symposium at EHA2024 Hybrid Congress

Hybrid symposium at EHA2024 Hybrid Congress

The Lymphoma Hub and Multiple Myeloma Hub would like to invite you to join their hybrid symposium: ‘Sequencing immune-based therapies in B-cell malignancies’. By attending this event you will enhance your understanding of outcomes before and after CAR T-cell therapy in patients with large B-cell lymphoma, gain insight into the optimal sequencing of CAR T-cell therapies and bispecific antibodies in relapsed/refractory multiple myeloma, and explore upcoming immune-based therapies. There will also be a live Q&A session, providing the opportunity to engage directly with our expert panelists. 

By attending this symposium, you may receive 1.5 CME credits awarded by the European Board for Accreditation in Hematology (EBAH). 

Mark your calendar for an informative session that promises to enrich your clinical practice and decision-making. We look forward to your participation! 

Date: Saturday, June 15, 2024; 18:00–19:30 (CEST) 

Location: Room N103, IFEMA Madrid Recinto Ferial (fairgrounds), Madrid, ES, and Online 

Speakers: Ulrich Jäger (Chair), Sagar Lonial, and Krina Patel 

EHA session details

Discover partnership opportunities